Rolls-Royce Corp. said Monday that the U.S. Air Force has awarded its Indianapolis operations an $8.5 million contract to
provide spare engine parts for the C-130J military transport aircraft.
Mike’s Express Carwash uses a lot of water. There’s just no getting around it. So when automated systems engineer
Ryan Binkley looked for ways to conserve resources, he focused on the company’s irrigation systems.
Eli Lilly and Co.’s Byetta won a new market approval, which the company hopes will reverse the diabetes
drug’s recent sales decline. But the drug also was the subject of a new alert about kidney problems in patients taking
the drug. The U.S. Food and Drug Administration OK’d Byetta to be used sooner in patients suffering from poor blood
sugar control. But the FDA also told doctors to be alert about kidney problems of some patients taking Byetta.
Before, the FDA called for Byetta to be used only after patients tried other drugs without success. Byetta, which Lilly sells
via a partnership with San Diego-based Amylin Pharmaceuticals Inc., suffered a 5-percent decline in U.S. sales in the 12 months
year, to $171 million in the third quarter. Worldwide Byetta sales totaled $593 million through
the first nine months of this year, a 5-percent increase compared with the same period in 2008.
Lilly
also will trim 191 sales jobs in Indiana as part of a company-wide restructuring announced in September that ultimately
will result in 5,500 job cuts by the end of 2011. The pharmaceutical giant will trim its osteoporosis, diabetes and neuroscience
sales forces, which are listed as working out of the Lilly Technology Center on South Harding Street. The workers’ last day
will be Dec. 31.
Local health care information technology professionals will discuss efforts to bring Indiana health
care into the digital age at a breakfast meeting on Friday. The panelists will include Jane Niederberger, president of Indianapolis-based
My Health Care Manager LLC, Stacy Cook, a physician attorney at
the Indianapolis law firm of Barnes & Thornburg LLP, Michael E. Rudicle, a director at
the local office of New York-based accounting firm PricewaterhouseCoopers LLP, and Jack Horner, CEO of Major
Hospital in Shelbyville. The meeting, part of the New Economy New Rules series, will be held at the downtown offices
of the Barnes & Thornburg law firm.
Wishard Foundation said it has received a $6 million
grant from the Indianapolis-based Richard M. Fairbanks Foundation
to help fund construction of a new Wishard Hospital. Voters on Tuesday approved a new $754 million hospital
for Wishard Health Services. The $6 million grant is the single largest philanthropic contribution Wishard
has received in its 150-year history.
The FDA said a new titanium implant
to re-stabilize the spine, made by Zimmer Holdings Inc., showed good
results in a clinical trial. But the FDA also noted that physicians who had received consulting payments from Warsaw-based
Zimmer turned in patient results better than physicians who were not paid by Zimmer, according to the Associated Press. The
FDA noted the correlation was not statistically significant, but it will asks a panel of orthopedic specialists to weigh in
on the new device and decide whether Zimmer should provide more data before approving it for sale. The agency is not required
to follow the group’s advice, though it usually does.
Eli Lilly and Co. has notified the state that it plans to eliminate 191 sales jobs as part of a company-wide restructuring
announced
in September
that ultimately will result in 5,500 job cuts by the end of 2011.
Lilly is opening the San Diego biotech center a year after launching a biotech R&D center in Indianapolis.
Long tracking the emergence of information technology firms involved in the health and life sciences sector, the state’s
IT trade group, TechPoint, is undergoing a mitosis of sorts to help fuel the trend. It has created Advancing
Life Science & Health Care Information Technology, or ALHIT, which will focus on growing this subset of the IT realm.
Count Butler University basketball on the short list of teams that could make it to the Final Four.
As it shrinks its work force, Indianapolis-based pharmaceutical firm Eli Lilly and Co. will move more than 1,000 employees to its corporate
center
by mid-2010.
The drug maker said its settlement with South Carolina is the largest such settlement it has reached over Zyprexa. It previously
settled with the state of Connecticut for $30 million.
South Carolina Attorney General Henry McMaster said Friday that the state has reached a $45 million settlement with drug maker
Eli Lilly and Co. over the company’s marketing of an anti-psychotic drug.
Sales of Eli Lilly and Co.’s newest drug were an afterthought during its Oct. 21 report on third-quarter earnings. The blood thinner Effient totaled up $22.6 million in sales—a mere 0.4 percent of Lilly’s total for
the quarter.
Goodwill Industries executive Keith Reissaus has been tapped to run Washington, D.C.-based Leapfrog Group, an industry coalition.
Reissaus gained control of health care costs by giving employees incentives to care about their health.
Eli Lilly and Co. and General Electric Co. say they’ve made a breakthrough in cancer research that could help Lilly cut the size and cost of its clinical trials.
For the first time publicly, Eli Lilly and Co. officials admitted the obvious: Their pipeline products
aren’t likely to offset the revenue the company will lose after its two bestsellers, Zyprexa and Cymbalta, lose patent exclusivity.
Excluding special items, Eli Lilly and Co.’s earnings per share spike 22 percent on the strength of Alimta, Cymbalta and Humalog
sales. Lilly’s revenue rose 7 percent in the quarter over the same period of 2008,
to $5.56 billion.
Medco Health Solutions Inc. said Tuesday it will compare the blood thinner Plavix, the world’s second-best selling drug, with
Effient, a potential blockbuster drug sold by Indianapolis-based Eli Lilly and Co.
Idaho is getting $13 million as part of a settlement reached with Indianapolis-based Eli Lilly and Co. over its marketing of
anti-psychotic drug Zyprexa.
The museum finally has a brand—it bills itself as a “center for science
and culture”—but don’t expect a splashy campaign.
The health reform bill sponsored by U.S. Sen. Max Baucus, D-Mont., would help pay for expanded health insurance coverage
by levying fees of $13 billion a year on the health care industry. The fees would deliver a hefty bill to just
about all of Indiana’s major health care companies. But how they’re reacting to the fees is all over the map.
